We had previously demonstrated that Rab3a-GTP inhibits and the Rab3a-binding protein Rabphilin3a enhances secretion in bovine chromaffin cells. In this study, we investigated the role of Rab3a-GTP binding in the intracellular expression and the function of Rabphilin3a in regulated exocytosis in bovine chromaffin cells. Using transient transfections, we found that a minimal domain, , that inhibits secretion coincides with a minimal domain that effectively binds Rab3a-GTP and allows intracellular stability of the construct. This domain includes a cysteine-rich, Zn2~-binding domain whose integrity is also required for Rab3a-GTP binding and the ability to inhibit secretion. A Rabphilin3a mutant, containing both 02 domains but defective in Rab3a-GTP, and wild-type Rabphilin3a both localized to chromaffin granules and stimulated secretion similarly despite lessened intracellular expression of the mutant protein. The data are consistent with a sequence of events in which a Rab3a-GTP Rabphilin3a complex forms on the secretory granule as a precursor in a pathway that enhances secretion. The complex dissociates (perhaps because of GTP hydrolysis) to permit the enhancement of secretion by Rabphilin3a. Key Words: Exocytosis-Rabphilin3a-Rab3a-Adrenal chromaffin cells.
The Rab class of low-molecular-weight GTPases has been implicated by genetic and biochemical studies to be involved in vesicular trafficking in eukaryotic cells (Novicketal., 1980; Gallwitzetal., 1983; Pfeffer and Rothman, 1987; Goud et al., 1988; Segev et al., 1988; Plutner et al., 1991; Tisdale et al., 1992; Lombardi et al., 1993; Pfeffer, 1994) . Distinct Rab proteins are necessary for trafficking in the constitutive secretory (Tisdale et al., 1992; Elazar et al., 1994; Nuoffer et al., 1994) and endocytosis pathways (van der Sluijs et al., 1991 (van der Sluijs et al., , 1992 Bucci et al., 1992; Lombardi et al., 1993; Barbieri et al., 1994) and may regulate docking and/or fusion through as yet unknown mechanisms. There is evidence that Rab proteins may indirectly modulate the function of another set of proteins, the SNARE proteins, that also play a role in vesicular trafficking pathways (Lian et al., 1994; Sogaard et al.. 1994) .
Rab3a is found mainly in cells, including neurons and chromaffin cells, with a highly differentiated Ca2-dependent secretory pathway. We (Holz et al., 1994) and others (Johannes et al., 1994) had previously demonstrated that Rab3a is a negative regulator of exocytosis, in experiments with bovine chromaffin cells and PC12 cells. Investigation of the effects of various mutants indicates that GTP-bound rather than GDP-bound Rab3a is inhibitory. Experiments with permeabilized chromaffin cells suggest that Rab3a acts upstream of the final fusion events triggered by Ca2ã nd may be involved in preparing the granules to undergo exocytosis (Holz et al., 1994) .
A possible effector for Rab3a is Rahphilin3a, a Rab3a-binding protein. Rabphilin3a was initially identified as an 85-kDa protein that bound Rab3a with a much greater affinity for the GTP-than the GDP-bound form. Cloning of the Rabphilin3a revealed a 704-amino-acid protein in bovine brain (Shirataki et al.. 1993 ) and a 710 splice variant in bovine chromaffin cells (Chung et al., 1995) . Both Rab3a and Rabphilin3a are found on synaptic vesicles and chrornaffin granules (Darchen et al., 1990 (Darchen et al., , 1995 Mollard et al.. 1990; Li et al., 1994; Mizoguchi et al., 1994; Chung et al., 1995) , which suggests that the proteins interact on the secretory vesicle or chromaffin granule membrane. Another Rabphilin3a-binding protein is also associated with synaptic vesicles (Shirataki et al., 1994) .
A transient transfection technique based on the expression of human growth hormone (hGH) as a reporter for the regulated secretory pathway was used to study the effects on regulated secretion of cotransfected Rabphilin3a in bovine chromaffin cells (Chung et al., 1995) . Overexpression of Rabphilin3a enhanced 1,1 -dimethyl-4-phenylpiperazinium (DMPP) -induced hGH secretion~-~30%. Secretion by chromaffin cells transfected with a plasmid with the entire coding sequence of Rabphilin3a inserted in the antisense orientation was inhibited by~-~30%, indicating that endogenous Rabphilin3a regulates Ca 2-dependent secretion (Chung et al., 1995) . The N-terminal half of Rabphilin3a binds Rab3a-GTP and the C-terminal half has tandem C2 domains (Shirataki et al., 1993) that are responsible for Ca2~and phospholipid binding of the protein. Deletion of one or both of the C2 domains converts the protein from an enhancer to a strong inhibitor of Ca2~-dependentexocytosis.
The opposite effects on secretion of Rab3a and Rabphilin3a suggested a sequence of events in which a Rab3a-GTP Rabphilin3a complex forms on the secretory granule as a precursor in a pathway that enhances secretion. The complex dissociates (perhaps because of GTP hydrolysis) to permit the enhancement of secretion by Rabphilin3a. Overexpressed Rab3a bound to GTP may inhibit secretion by binding and reducing the amount of activated Rabphilin3a on the chromaftIn granule.
The sequential model is compatible with the inhibition of secretion caused by expression of the Rabphilin3a deletion mutants lacking one or both of the C2 domains. Because these mutants bind Rab3a-GTP, they tnay inhibit secretion by competing with endogenous Rabphilin3a for interaction with Rab3a-GTP without being able to mimic the functional effects of full-length Rabphilin3a. Reduced interaction of endogenous Rabphilin3a with Rab3a may also result in increased degradation of endogenous Rabphilin3a and! or Rab3a Li et al., 1994) .
In this study, we tested the model by analysis of the Rabphilin3a mutants that are unable to bind Rab3a-GTP. We defined Rabphilin3a mutations that interfere with Rab3a-GTP binding. We determined the intracellular stability and function in secretion of constructs with and without the C2 domains that were deficient in Rab3a-GTP binding.
MATERIALS AND METHODS

Chromaffin cell preparation, transfection, and secretion experiments
Chromaffin cell preparation, transient transfection, and secretion experiments were performed as described previously (Wick et al., 1993; Holz et al., 1994 Chung et al., 1995) . Ca2~phosphate precipitation was used for transfections according to Wilson et al. (1996) in 12-well plates (22.6-mm well diameter). Secretion experiments were generally performed 5-6 days after transfection at 27°C. hGH was measured with a high-sensitivity chemilurninescence assay from Nichols Institute (San Juan Capistrano, CA, U.S.A.). Endogenous catecholamine secretion was measured with a fluorescence assay (Holz et al., 1982) . Because only 1 -4% of the cells are transfected, catecholamine secretion mainly reflects secretion from nontransfected cells. It is not altered by transfection and served as a control in the hGHsecretion experiments. Secretion was expressed as the percentage of the total cellular hGH (or catecholamine) that was released into the medium. There was usually 0.5-2.0 ng hGH and 20-40 nmol catecholamine /22.6-mm-diameter well.
Construction of expression vectors
The deletion mutants of Rabphilin3a were made by PCRs from plasmid containing full-length bovine chromaffin cell Rabphilin3a (Chung et al., 1995) . Primers were designed to generate 5'-Ba,nHl and 3'-EcoRl restriction sites. PCR products were digested with BamHl and EcoRI and subcloned into pCMV-hemagglutinin (pCMV-HA), a mammahan expression vector that is under the control of human cytomegalovirus (CMV) promoter and contains the HA 1 epitope (YPYDVPDYA), and pGEX-2T (Pharmacia). The construction of internal cysteine deletions of Rabphilin3a(1-206) IRp(l-206)1 has been described previously (McKiernen et al., 1996) .
Rab3a-binding assays
Rab3a-binding assays were performed as described previously (McKiernen et al., 1996) . The glutathione-S-transferase-Rabphilin3a (GST-Rabphilin3a) fusion proteins and GST protein were attached to glutathione-Sepharose beads (Pharmacia) and incubated with Rab3a-[y-32PIGTP in 50 mM HEPES, pH 7.5, 150 mM NaCI, 10 mM MgCl 2, 0.2 mg/mI bovine serum albumin, and 1 mM GTP. After incubation on ice for 10 mm, the beads were rinsed with wash buffer (50 mM HEPES, pH 7.5, 150 mM NaCI, 10 mM MgCl2). The amount of Rab3a bound to heads was determined by scintillation counting.
Full-length Rabphilin3a and short N-terminal deletions were not well expressed in bacteria. Instead, HA3-Rabphilin3a IHA3-Rp(l---710)1 and HA5-Rp(71-710) were expressed in COS cells in 100-mm-diameter plates. Two days after transfection, the proteins were immunoprecipitated from homogenates by using protein A-Sepharose. The binding of Rab3a-[y-3PIGTP to the immunoprecipitates was determined.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), western analysis, and immunocytochemistry
The GST-Rabphilin3a fusion proteins bound to glutathione-Sepharose beads were eluted with It) mM glutathione (Sigma) in 50 mM Tris-HCI, pH 8, and separated by SDS-PAGE.
Protein expression was examined by transient transfection of bovine chromaffin cells in 35-mm-diameter dishes by calcium phosphate precipitation (Wilson et al., 1996) . After 6 days, cells were harvested into sample buffer and subjected to 12 or 15% SDS-PAGE, followed by immunoblotting with anti-HAl antibody (1:5,000 dilution). The enhanced chemiluminescence detection method (Amersham) was used according to the manufacturer's instructions.
Immunocytochemistry to determine expression of hGH and the HA 1 epitope was performed with conventional fluorescence microscopy as previously described (Holz et al., 1994). Confocal microscopy was performed as previously described (Schroeder et al., 1994) to examine the colocahization of hGH-containing granules and Rabphilin3a and mutants in transfectcd chromaffin cells. Overlap in the FITC channel (hGH) and the hissamine-rhodamine channel (HA 1-Rabphilin3a) was determined by multiplication of the images, pixel by pixel, in the two channels by using NIH Image (version 1.59). The m'esulting pixel intensities were normalized to fit an eight-bit scale. Figure I is a schematic of chromaffin cell Rabphilin3a. Several Rabphilin3a truncation mutants were expressed as GST fusion proteins and tested for their ability to bind Rab3a-[y32PjGTP. The GST fusion proteins were attached to glutathione-Sepharose beads and incubated with Rab3a-[y-32PjGTP. The amount of bound Rab3a was determined after rapid washing of the heads. GST-Rp( 1-206) bound 100-fold more Rab3a-[y-32P]GTP than GST alone (Table I) . Similar binding was obtained with , , amid Rp(5l--l90), which indicates that the first 50 amino-terminal amino acids are not important for Rab3a-GTP binding. It is noteworthy that deleting nine additional amino-terminal amino acids and 1 completely eliminated Rab3a-GTP binding.
RESULTS
Specific amino-terminal domains are necessary for the binding of Rabphilin3a to Rab3a-GTP
TABLE 1. The t,bilizv of N-and C-terminal deletion mutants to inhibit secretion requires' biimding to Rah3a
/õf inhibition of -206) 333.400 48 ± 6 (3) 326,700 60 ±4 (6) 279,300 61 ± 5 (2) 267,000 48 ±8 (2) 3,225 4 ± ll~4) 3.570 -2 ± 8 (3)
Rah3a-[y-2PjGTP binding to GST-Rabphilin3a mutants was determined. The mean of duplicate determinations is presented. Inhibition of DMPP-induced hGH secretion was determined in translècl ion experiments. Data are mean ±SEM values l'rom individual experiments. The numbers in parentheses indicate the numbers of individual experiments.
The binding of Rah3a-GTP to Rp(71-710) containing both C2 domains was also examined. The binding of Rab3a-[y-12P}GTP to immunoprecipitated Rp(7 1-710) was 1% of the binding to Rp( 1-710) (n = 2). Thus, as with shorter constructs ( Table I ), residues that are N-terminal to amino acid 71 in a Rahphihin3a mutant containing both C2 domains are important fbr the binding of Rab3a-GTP.
While this study was iii progress, Stahl et al. (1996) and McKiernen et al. (1996) presented a mutational analysis of components of Rahphilin3a structure necessary for binding to Rab3a-GTP. Although amino acids 51 -59 were not investigated, the regions found to encompass the Rab3a-GTP binding domain in these studies. i.e., residues 40-170 (Stahl et al., 1996) and 45-170 (McKiernen et al., 1996) , are in excellent agreement with the present study.
Rabphilin3a constructs unable to bind Rab3a-GTP have reduced stability when expressed in chromaffin cells
To investigate the importance of Rab3a-GTP binding for the intracellular stability of Rabphihin3a, plasmids encoding HA-tagged Rabphilin3a mutants were transiently transfected together with pXGH5 (which encodes hGH) in chromaffin cells. Five to 6 days later, cell homogenates were subjected to SDS-PAGE and immunoblotting with anti-HA amitibody. Despite transfection of only 1 -4% of the chromaffin cells, mutants that bind Rab3a-GTP could be readily detected. Figure 2A demonstrates the expression of . , . However, Rabphilin3a mutants that do not bind Rab3a-GTP, i.e., amid Rp(60-206), were not well expressed.
The poor expression of constructs that do not bind Rah3a-GTP was not caused by low transfection efficiency, because cotransfected hGH was expressed similarly in experiments with Rahphilin3a constructs with and without the ability to bind Rab3a-GTP. For example, in Fig. 2Al . , Rp(5l-l90), , and CMV.neo expressed 3.0,4.3,4.9, amid 5.4 ng hGH/well, respectively. The Rabphilin3a constructs without the ability to bind Rab3a-GTP are not intrinsically unstable, because they could be expressed as GST fusion proteins in bacteria similarly to mutants that bind Rab3a-GTP (Fig. 2B) .
The actual coexpression of hGH and HA-tagged Rahphihin3a mutants in individual cells was examined by immunocytochemistry using conventional fluorescent microscopy (Fig. 3 ). Cultures were transfected with hGH and either HA-Rp(51-206) or HARp(60-206). The Rab3a-GTP-binding mutant HA- was almost always expressed in hGHcontaining cells. Figure 3A shows two hGH-expressing Chromaffin cells were cotransfected with pXGH5 encoding hGH and plasmids encoding HA-tagged Rabphilin3a mutants. The cultures were prepared for immisunocytochemistry 6 days later. The expression of HA-Rabphilin3a mutants was evaluated in 3(1-4(1 hGH-expressing cells in each transfected culture. Rp(l -206~2cys) is HA-Rp( 1-21)6) with amino acids 97-102 deleted. which contain the first two cysteines in the Zn-binding domain. This deletion reduces the Rab3a-GTP binding by 83% compared with Rp( I -206) (McKierncn et al., 1996) . The immunolluorescence due to Rahphilin3a mnutants that do not hind Rab3a-GTP well termded to be less bright in expressing cells thami immunofluorescence due to Rah3a-GTP-binding mutants. In four experiments, the coexpression of HARp(71-710) and hGH was evaluated by immunocytochemistry. The percentage of the hGH-expressing cells that coexpressed the mutant protein 3 or 4 days after transfection was 48~9%. The coexpression is significantly less than the 90% for Rabphilin3a constructs that bind Rab3a-GTP including both C2 truncations (Table 2 ) and full-length Rabphilin3a (Chung et al., 1995) .
Rp
Because an endogenous protein gave a signal with the anti-HA antibody that coincided with the expected band from HA-Rp(71-710), immunoblots could not detect the transfected protein.
Serial N-and C-terminal deletions of Rp(1-536) define a minimal region necessary for inhibition of secretion that corresponds to the Rab3a-GTP binding domain
In a previous study, we found that deletion of one or both of the C-terminal C2 domains of Rabphilin3a converted the protein from one that enhanced to one that inhibited secretion when transiently expressed in bovine chromaffin cells (Chung et al., 1995) . To determine the minimal region necessary for inhibition, Nand C-terminal deletion mutants were constructed from Rp(l-536). Rp(l-536) lacks the region encoding the most carboxy-terminal C2 domain. The plasmids were tested for their effects on hGH secretion after transient expression (together with hGH) in bovine chromaffin cells. The inhibitory effects on secretion of various constructs from a large number of experiments are summarized in Fig. 4 . Stimulation with the nicotinic agonist DMPP for 2 mm in cells not expressing exogenous Rabphilin3a constructs caused vigorous hGH secretion (10-15% of the total expressed hGH, which was normalized to 100% for each experiment).
Rp( 1-536) inhibited hUH secretion 60%, a result that is consistent with a previous study (Chung et al., 1995) . Deletion of the N-terminal 50 amino acids had little or no effect on the ability of the connstructs to
FIG. 4. Effects on secretion of serial deletions from the N-terminus (A) and Cterminus (B) of RpAC2B [Rp(1-536)l.
A: Chromaffin cells were cotransfected with a plasmid encoding hGH (pXGH5) and either pCMVneo or serial N-terminal deletions of Rp(1-536) that encodes Rabphilin3a without the one C2 domain. B: Chromaffin cells were cotransfected with a plasmid encoding hGH (pXGH5) and either pCMVneo or serial C-terminal deletions of Rp(1 -536). All constructs were HA 1 tagged at the amino terminus.
Five to 6 days after transfection, cells were incubated ±20pM DMPP for 2 mm. Data are presented as percent inhibition values of OMPP-dependent secretion compared with hGH secretion from cells transfected with control plasmid pCMVneo. The numbers of experiments performed are indicated in parentheses adjacent to error bars. inhibit secretion. However, deletion of the next nine amino acids almost completely prevented the inhibition, with further N-terminal deletions having no effect on secretion (Fig. 4A) .
C-terminal deletions of Rp( 1-536) also revealed a region necessary for the inhibition of secretion (Fig.  4B) . As shown in a previous study (Chung et al., 1995) , removal of both C2 domains [Rp(1-286)1 results in a protein that inhibits secretion similarly to . and Rp(1-190) also significantly inhibited secretion. The inhibition decreases with larger C-terminal deletions.
The data suggest that the small fragment Rp(51-190) should inhibit secretion. Figure SA demonstrates that this is, indeed, the case. Whereas and Rp(51-l90) are equally effective as Rp(l-536) in inhibiting secretion, ) is without effect.
As summarized in Tables 1 and 2 , the minimum domain of Rabphilin3a that inhibits secretion binds Rab3a-GTP and is well expressed in transfected chromaffin cells. Constructs that do not bind Rab3a-GTP have low intracellular stability and do not inhibit secretion.
Deletion in the Zn2~-bindingdomain of Rabphilin3a prevents inhibition of secretion by truncated Rabphilin3a [Rp(1-206)I
Rabphilin3a binds Zn2~in a region from C98 to C144 that contains nine cysteines in CXXC motifs (McKiernen et al., 1996; Stahl et al., 1996) . Deletion of amino acids R97-G102, which removes the first CXXC motif ] reduces by 70% the ability of the protein to bind Zn2~and reduces the Rab3A-GTP binding by 83% (McKiernen et al., 1996) . This construct is not well expressed when transfected into chromaffin cells (Table 2 ) and was not able to inhibit secretion (Fig. SB) . In five experiments, secretion was inhibited by 5 ±10%.
Carboxyl terminal-containing constructs deficient in Rab3a binding are located on secretory granules and are able to enhance secretion Full-length Rabphilin3a has been previously shown to be associated with synaptic vesicles and chromaffin granules. The localization of an N-terminal deletion, HA-Rp(71-710), which is unable to bind Rab3a-GTP, was investigated by confocal microscopy. When present in an hGH-expressing cell, HA-Rp(71-710) (Fig. 6B) as well as HA-Rp(l-710) (Fig. 6E) had distinctly punctate appearances in chromaffin cells. Both colocalized with hGH-containing secretory granules ( Fig. 6C and F) .
The role of Rab3a-GTP binding in the enhancement of secretion by Rabphilin3a was investigated. Because the enhancement of secretion by wild-type Rabphilin3a is relatively small (~-~30%) (Chung et al., 1995) , a large number of experiments were required to determine the effects of various constructs on secretion. Two mutants were investigated with deletions of Nterminal segments that are required for Rab3a-GTP binding, i.e., HA-Rp(71-710) (six experiments) and HA-Rp(81-710) (three experiments) (Table 3) . Secretion stimulated by either 20 ,uM DMPP or elevated K~for 8, 10, or 20 mm was increased in all experiments with an average enhancement of 29.4 ±2.7% (p < 0.0001, vs. transfection with pCMVneo, paired t test). This is similar to the~-~30% enhancement of full-length Rabphilin3a reported previously (Chung et al., 1995) . Thus, although the proteins were relatively unstable within the cell, they were, nevertheless, able to enhance secretion. Because only 48% of the hGHcontaining cells coexpressed HA-Rp(7 1-710) (see above), the protein may have enhanced hGH secretion 60% in those cells expressing the mutant.
DISCUSSION
In this study, we investigated the role of Rab3a-GTP binding in the function of Rabphilin3a in regu- and Rabphilin3a channels are indicated. Overlapping structures in A and B, and in 0 and E, are shown in C and F, respectively. Overlapping structures were determined by pixel-by-pixel multiplication in A and B, or in C and D, as described in Materials and Methods. The calibration bar corresponds to 2 pm. lated exocytosis. We found that constructs with decreased ability to bind Rab3a-GTP have decreased stability when expressed in chromaffin cells. The inability to bind Rab3a-GTP was associated with the loss of inhibitory action of C2 deletion mutations. Rabphilin3a mutants containing both C2 domains but defective in Rab3a-GTP binding enhanced secretion similarly to the wild-type protein despite decreased intracellular stability. These results are consistent with a sequential model for the action of Rah3a and Rabphilin3a and suggest that Rabphilin3a not bound by Rab3a-GTP enhances secretion (see below).
The minimal inhibitory region of Rabphilin3a coincides with the minimal Rab3a binding domain
In a previous study, we demonstrated inhibitory effects of Rabphilin3a mutants lacking one or both carboxyl-terminal C2 domains in Ca 2 -dependent exocytosis in bovine chromaffin cells (Chung et al.. 1995) . In the present study, the minimal inhibitory domain was mapped to residues 51 -190 of Rabphilin3a. It coincided with the minimal Rab3a-GTP binding domain. Deletion of just nine additional aminoterminal amino acids resulted in a construct )J unable to bimid to Rab3a-GTP and unable to inhibit secretion.
Rabphilin3a mutants defective in Rab3a-GTP binding [including Rp(60-l90)I were poorly expressed compared with Rab3a-GTP binding constrtmcts. The low expression was not caused by poor transfection. because the plasmid emicoding hGH that was cotransfected with these constructs was well expressed. The low expression probably reflects poor intracellular stability of the protein. At this time, we cannot determine whether the loss of inhibitory effect on secretion results Chromnaffin cells were transfected with a plasniid encoding hGH and either pCMVnco or plasniids encoding HA 1-Rahphilin3a(7I -710) or . These Rahphilin3a constrtmcts contain both C2 domnains hut nom the amino-terminal domaimi necessary 'or Rah3a-GTP bimiding. Thi'ee to 6 days after transfection secretion was stimulated with either elevated K~ (56 mM solely from poor stability of the mutant proteins in the cell or, in addition, from the inability of the expressed protein to bind Rab3a-GTP. The effect of Rab3a binding to confer intracellular stability to Rahphilin3a is consistent with the decrease of Rabphilin3a expression in the CNS of Rab3a knockout mice .
In a previous study, Rabphilin3a mutants deficient in Rab3a-GTP binding were relatively well expressed in transiently transfected PCI2 cells (McKiernen et al., 1996) . The seemingly greater stability in PCI2 cells than in chromaffin cells may be the result of a larger N-terminal epitope (three consecutive HA peptides) used in the former study compared with the smaller N-terminal epitope (a single HA peptide) in the present experiments. The large N-terminal addition may have protected against proteolysis. An alternative possibility is that the different stabilities could reflect differences in the cell types.
Rab3a-GTP binding is not necessary for fulllength Rabphilin3a to enhance secretion
To investigate the role of Rab3a-GTP binding in the enhancement of secretion by full-length Rabphilin3a, two mutants were investigated with deletion of N-terminal segments that are necessary for Rab3a-GTP binding, i.e., Rp(71-7 10) and Rp (81-7 10). The mutants were able to enhance hUH secretion despite their deficient expression in hGH-containing cells.
These results are consistent with the finding that Doc2 also enhances secretion when overexpressed in PCI2 cells (Orita et al., 1996) . Doc2 is a synaptic vesicle protein that has two C2 domains with sequence homology to that of Rabphilin3a (62% identity over 323 amino acids) but does not bind to Rab3a-GTP (Orita et al., 1995) . The data suggest that endogenous Rabphilin3a can enhance secretion after binding to Rab3a is terminated by GTP hydrolysis.
The inability of Rp(71-710) to bind Rab3a-GTP did not prevemit the protein from associating with secretory granules (Fig. 6) . A previous study also demonstrated that Rabphilin3a mutants deficient in Rab3a-GTP binding could associate with Rab3a-containing membrane organdIes in PCI2 cells (secretory granules), although to a somewhat lesser degree than wildtype protein (McKiernen et al.. 1996) . Indeed, a proteimi binding site, in addition to Rab3a-GTP, is probably important for the association of Rabphilin3a to secretory vesicles (Shirataki et al., 1994) .
We had found that the Rp(287-710) with a large N-terminal deletion did not enhance secretion (Chung et al., 1995) . The ability of Rp(81-710) to enhance secretion suggests that the region between amino acids 81 and 287 is necessary for the enhancement of secretion. The overlap of this region with the Rab3a-GTP binding doniain (amino acids 51 -190) raises the possibility that Rab3a-GTP controls the accessibility of the region to other componemits in the secretory pathway.
A model for the role of Rabphilin3a in regulated secretion
Recent cross-linking experiments with synaptosomes (Stahl et al.. 1996) and confocal immunocytochemical experiments with PCI2 cells (McKiernen et al., 1996) provide stromig evidence that Rab3a and Rubphilin3a are colocalized and interact on secretory granules and vesicles. The opposite effects of Rab3a-GTP to inhibit secretion and full-length Rabphilin3a to enhance secretion (Holz et al., 1994; Johannes et al., .1. jima/u's, , Vol. 69, No. I, /997 S.-I-I. CHUNG ET AL. Doctoral Fellowship from the American Heart Association of Michigan (S.-H.C.).
REFERENCES
FIG. 7.
Sequential events in Rab3a/Rabphilmn3a control Ca 2~-dependent exocytosis. Rab3a-GTP and Rabphilin3a interact on the secretory granule membrane. Rabphilin3a mutants without one or both C2 domains compete with endogenous Rabphilin3a for binding to Rab3a-GTP. RpBP is a putative Rabphilmn3a-binding protein distinct from Rab3a that is suggested to participate, together with Rab3a-GTP, in the binding of Rabphilin3a to secretory granules (Shirataki et al., 1994) . GTP hydrolysis (step 1) results in dissociation of Rabphilmn3a and Rab3a and the activation of Rabphilmn3a function. This is consistent with Rabphilin3a mutants containing both C2 domains but defective in Rab3a-GTP binding enhancing secretion similarly to the wild-type protein.
Step 2 represents unknown effector pathways for activated Rabphilmn3a. Overexpression of Rab3a in transfection experiments results in inhibition of secretion because ofrapid rebinding of activated Rabphilin3a by abundant Rab3a-GTP to functionally reverse step 1. Because overexpression of Rab3a and mutants preferentially alters the initial secretory response, it is suggested that the Rab3a/Rabphilin3a pathway regulates the number of primed granules.
1994; Chung et al., 1995) suggest a sequence of events in which Rab3a-GTP and Rabphilin3a form a complex on the secretory granule that is a precursor in a pathway that enhances secretion (Fig. 7) . Rabphilin3a then dissociates from Rab3a, possibly because of GTP hydrolysis, in order for enhanced secretion to occur. The findings of this study support the model. Rabphilin3a mutants containing both C2 domains but defective in Rab3a-GTP binding and Rp(81-710)] were able to enhance secretion. This effect was observed despite limited stability of the protein in transfected cells.
The ability of the mutants to enhance secretion eliminates an alternative model in which Rabphilin3a would enhance secretion by preventing direct, inhibitory effects of Rab3a-GTP on secretion.
